European Archives - Page 582 of 1232 - European Medical Journal

Congress Interview - Aleksander Krag

EASL 2022 Congress Interview: Aleksander Krag

Hepatology is an exciting and challenging clinical discipline with many great research opportunities and a vibrant international community.

EMJ Hepatology 10.1 Feature Image

Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences

Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions of the world and are on trajectory to become the most common liver disease at a global scale. Risk for high prevalence and progressiveness include visceral obesity and Type 2 diabetes.

Post-traumatic Isolated Right Hepatic Duct Injury: A Case Report

A 73-year-old female presented with a rare presentation of extrahepatic ductal injuries post-trauma in the form of a right hepatic duct injury. Such injuries go undetected despite normally advised imaging, presenting a few to several days post-trauma.

EMJ Diabetes 10 [Supplement 1] 2022

With the incidence of diabetes rising annually across the globe to an estimated 537 million adults, healthcare expenditure is also rising. To gain a wide perspective of diabetes care, EMJ discussed a range of pertinent topics with four international experts.

The Association of Serum Progesterone Levels on Day of Oocyte Retrieval with Pregnancy Outcome

To establish the level of serum progesterone (P4) on the day of oocyte retrieval beyond which it can affect the outcome of in vitro fertilisation (IVF), and to further establish the incidence of serum P4 rise in an agonist and antagonist cycle.

Future Management of Patients with Oesophageal Cancer

This EMG Health podcast kicks off with Bridget Scott introducing two experts, David Ilson and Samuel Klempner, who discuss critical unmet needs in the management of patients with oesophageal cancer.

A pandemic response in 100 days

This infographic looks at the mission to make an effective vaccine against any virus in just 100 days and explores the diseases that are re-emerging that could be combatted with an expedited approach.

Current and future management of EGFR-positive NSCLC

This educational webinar has been organised and funded by The Janssen Pharmaceutical Companies of Johnson & Johnson. The content

Access win for HIV patients in sub-Saharan Africa

The injectable HIV treatment cabotegravir is set to become more widely available in sub-Saharan Africa following a new licensing agreement.

Unpacking the Immune System

This week, Peter Arkwright, Senior Lecturer in Paediatric Allergy and Immunology, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK, joins Evgenia to speak about the prevalence of allergy and the challenges surrounding immune disease in children.